Sinclairs Hotels (SINCLAIR)

Cyclical

Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Current Price₹74.58
Market Cap₹382.3 Cr
P/E Ratio35.51
ROCE15.33%
ROE12.31%
Dividend Yield1.07%
Profit Growth27.3%
Debt/Equity0.28
Sales Growth28.4%
Promoter Holding62.66%
52-Week Range₹68.82 — ₹114.75
SectorLeisure Services
Book Value₹22.55

Strengths

Concerns

AI Analysis

Sinclairs Hotels is a small hotelier, and I always remind myself that a business is a business, not a ticker. Hotels are capital-intensive, cyclical, and highly sensitive to economic travel cycles. The balance sheet looks acceptable: debt/equity of 0.30 is low, and a Piotroski F-Score of 7/9 suggests improving fundamentals. ROE of 12.31% and ROCE of 15.33% are decent, but nothing exceptional for the risk embedded in this industry. The 415% profit growth and PEG of 0.13 grab attention, but I have learned to distrust numbers that come from a low base. A company emerging from a weak earnings period can show huge percentage growth without becoming a wonderful franchise. Sales growth of 23.35% is solid, yet the valuation is not forgiving. At ₹79.82, the market cap is ₹396 crore, which is 28.95 times trailing earnings and 3.63 times book value. Book value is only ₹22.01, so I am paying a large premium for a hotel business earning a mid-teen return on capital. The latest quarter shows revenue of ₹18 crore and net profit of ₹6 crore, a strong margin of 33%, but hotel quarter results can be seasonal and misleading. The dividend yield is just 1.03%, so I am not being paid to wait. Promoter holding of 62.66% is a positive sign, and low debt gives some comfort, but a nearly 29 price-to-earnings ratio leaves little margin of safety. Mr. Market is pricing in a perfect steady recovery. A value investor should prefer uncertainty at a discount, not at a premium. I would keep Sinclairs on my watchlist and wait for either a lower price or clearer evidence that its small hotel portfolio can compound consistently. For now, this looks like a cyclical recovery, not a compounding stalwart.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer